PMcardio receives FDA Breakthrough Device Designation — read the full story
Powerful Medical
1. October 2024
3 min to read

Evaluating AI Prediction of Occlusive Myocardial Infarction from 12-lead ECGs After Resuscitated Out-of-Hospital Cardiac Arrest

Overview

Rapid detection of coronary vessel blockage in out-of-hospital-cardiac-arrest (OHCA) patients is crucial, as timely treatment improves survival and neurological outcomes. Standard ECG criteria often miss critical markers, delaying treatment. This analysis showed that the PMcardio STEMI AI ECG Model could detect them with high accuracy (88.7% sensitivity, 81.4% specificity), demonstrating its potential to speed up diagnosis and improve patient care.

Published In: Journal of the American College of Cardiology (JACC) – presented at the TCT’24 Annual Conference
Presented Date: October 27, 2024

Background

Identifying occlusive myocardial infarction (OMI) on electrocardiograms (ECGs) after resuscitated out-of-hospital cardiac arrest (OHCA) remains challenging. Even in the absence of ST-elevation, acute lesions may still be present. We evaluated OMI prediction in post-OHCA ECGs by an artificial intelligence (AI) model (PMCardio-Queen of Hearts [Medicines and Healthcare Products Regulatory Agency registered and CE certified]).

Methods

In this retrospective study, the Al model was used to predict OMI on post-return of spontaneous circulation 12 lead ECGs of unselected OHCA patients who underwent coronary angiography at operator discretion in two high-volume cardiac arrest centers. AI predictions were compared to invasive coronary angiographic findings.

OMI was defined as elevated troponin by the fourth universal myocardial infarction definition with an acute culprit coronary stenosis with reduced flow (Thrombolysis In Myocardial Infarction flow grade S 2). We then evaluated the Al model’s performance for identifying angiographically confirmed OMI.

Results

A total of 160 OHCA cases were included, with a mean age of 64.9 +/- 14.92 years; 74% were male, and 80% had shockable rhythms. ST-segment elevation myocardial infarction criteria were present in 38% of cases, and 20% had a bundle branch block. On invasive coronary angiography, OMI was identified in 61% of cases.

The Al model demonstrated a sensitivity of 0.887 (95% Cl: 0.80-0.97), specificity of 0.814 (95% CI: 0.74-0.88), and a positive predictive value of 0.708 (95% CI: 0.612-0.804) with an area under the curve of 0.85.

Conclusion

The AI model demonstrates high sensitivity, specificity, and positive predictive value for OMI. However, since it was not specifically trained on post–return of spontaneous circulation (ROSC) ECGs, further training on OHCA datasets is necessary to enhance its accuracy in detecting ECG changes suggestive of OMI in post-OHCA patients.

This application may serve as a valuable adjunct to clinical assessment in identifying OHCA patients who could benefit from life-saving coronary intervention.

Authors: Uzma Sajjad, Rupert Simpson, Sarosh Khan, Michael McGarvey, Muhamad Abd Razak, Klio Konstantinou, Christopher Cook, Nilesh Pareek, Xue Qiang, Grigoris Karamasis, Thomas Keeble, John Davies

Author-Logo_PM
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.

About PMcardio

PMcardio is the market leader in AI-powered diagnostics, addressing the world’s leading cause of death – cardiovascular diseases. The innovative clinical assistant empowers healthcare professionals to detect up to 40 cardiovascular diseases. In the form of a smartphone application, the certified Class IIb medical device interprets any 12-lead ECG image in under 5 seconds to provide accurate diagnoses and individualized treatment recommendations tailored to each patient.

About Powerful Medical

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Relevant Publications

Artificial Intelligence Detection of Occlusive Myocardial Infarction from Electrocardiograms Interpreted as “Normal” by Conventional Algorithms

Conventional ECG algorithms, humanly programmed to detect abnormalities based on fiducial points, frequently miss critical patterns of STEMI. AI-driven deep neural network models like PMcardio AI ECG offer significant potential in identifying these dangerous false negatives, reducing the risk of false reassurance, and enhancing clinical decision-making.

ECG Patterns of Occlusion Myocardial Infarction: a Narrative Review

This comprehensive review highlights the limitations of the traditional STEMI/NSTEMI classification for heart attacks and advocates for a more precise approach to diagnosis and patient triage. Instead of relying solely on standard ECG criteria, this method focuses on ECG patterns that more accurately reflect the severity of underlying coronary vessel disease. By identifying high-risk ECG changes beyond current STEMI guidelines, clinicians can detect heart attacks earlier, initiate treatment faster, and ultimately improve patient outcomes.

Join over 100,000 healthcare professionals who are already taking advantage of AI